Find clinical trials for Acute Myeloid Leukemia (AML) in Birmingham, AL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Birmingham, AL, USA:
CLN-049-001 is a Phase 1, open-label, multicenter, first-in-human trial of CLN-049 in patients with Relapsed/Refractory Acute Myeloid...
Phase 1
Birmingham, Alabama, United States and 10 other locations
to be used in future studies in study participants diagnosed with acute myeloid leukemia (AML), myelodysplastic s...
Phase 1, Phase 2
Birmingham, Alabama, United States and 33 other locations
The purpose of this study is to determine the recommended Phase 2 dose (RP2D) candidate(s) of bleximenib in combination with AML directed th...
Phase 1
Birmingham, Alabama, United States and 33 other locations
GDX012 is a novel cell therapy developed for the treatment of certain types of cancer, including Acute Myeloid Leukemia (A...
Phase 1, Phase 2
Birmingham, Alabama, United States and 13 other locations
This is a multi-center, randomized, double-blinded, placebo controlled trial.
Phase 3
Birmingham, Alabama, United States and 104 other locations
with fludarabine and cytarabine in treating patients with acute myeloid leukemia (AML), myelodysplastic syndrome ...
Phase 1
Birmingham, Alabama, United States and 17 other locations
it is safe for participants with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). It will study S...
Phase 1
Birmingham, Alabama, United States and 55 other locations
available therapy (BAT) on overall survival (OS) in subjects with acute myeloid leukemia (AML) who are in second ...
Phase 3
Birmingham, Alabama, United States and 72 other locations
survival (OS), and disease progression, including progression to acute myeloid leukemia (AML) in transfusion-depe...
Phase 2, Phase 3
Birmingham, Alabama, United States and 126 other locations
dose escalation groups (Group 1 in patients with relapsed/refractory AML, Group 2 in patients with relapse/refractory lymphoma/CLL/SLL). The...
Phase 1, Phase 2
Birmingham, Alabama, United States and 20 other locations
Clinical trials
Research sites
Resources
Legal